Cancer · 1985 · 25 citations · 19 references
MedicineOncologyPharmacotherapyBreast OncologyChemotherapyMetastasisBreast Cancer PharmacotherapyBreast Cancer RadiotherapyCancer StagingMalignant NeoplasmsBreast Cancer PrognosisDisease-free Survival AnalysisDisease-free Survival AssessmentDouble-blind TrialsPost-mastectomy RadiotherapyPost-recurrence PrognosisRecurrence-free SurvivalRecurrent Disease Therapy
The effect of levamisole combined with postoperative radiotherapy in Stage II breast cancer was investigated in a double-blind randomized study comprising 72 patients. All patients were followed for at least 5 years. Disease-free survival was slightly prolonged in the levamisole group as a whole. Among postmenopausal patients, levamisole significantly increased both disease-free and total survival (P = 0.003) and P = 0.008, respectively). The levamisole group also showed fewer distant metastases as the first sign of recurrence. Levamisole treatment was associated with a risk of granulocytopenia and agranulocytosis (10%), but, as in the authors' previous studies, this seemed to be totally reversible and did not worsen the prognosis.
19
BMDP Statistical Software 1981
W. J. Dixon · Biometrics · 1982 · 2.3K citations
Natural Sciences, Computer Science, Statistical Computing +8
Impaired immunologic reactivity and recurrence following cancer surgery
Frederick R. Eilber, Donald L. Morton · Cancer · 1970 · 667 citations
Life Sciences, Immunology, Oncology +14
IMMUNOSUPPRESSIVE EFFECT OF SURGERY
S. KWAN PARK, HerbertA. Wallace, JeromeI. Brody et al. · The Lancet · 1971 · 310 citations
Life Sciences, Immunology, Surgery +12